Increased HHR levels demonstrate an independent correlation with poorer 90-day recovery rates among ischemic stroke patients undergoing endovascular thrombectomy, positioning HHR as a potentially valuable indicator for clinical prognosis assessment.
Key Findings
Results
Higher HbA1c-to-hemoglobin ratio (HHR) independently predicted worse functional recovery at 90 days in patients undergoing endovascular thrombectomy.
Multivariate logistic regression yielded an adjusted OR of 10.484 (95% CI: 4.581–23.990; p = 0.001) for higher HHR levels upon hospital admission.
Poor clinical outcomes were defined as modified Rankin Scale scores of 3–6 at 90-day follow-up.
The study enrolled 353 participants with an average age of 70.5 years (SD 12.2); 218 were male.
Of the 353 participants, 181 (51.3%) showed adverse clinical results at 90 days.
Results
Restricted cubic spline analysis confirmed a nonlinear, dose-dependent relationship between HHR values and the likelihood of poor prognosis.
The nonlinearity p-value was 0.001, indicating a statistically significant nonlinear association.
The relationship was described as 'dose-dependent,' suggesting increasing HHR corresponds to increasing risk of poor outcome.
This analysis was used as additional investigation beyond the primary multivariate logistic regression.
Gao F, Chen S, Guo X, Xu W, Guan C, Wang S, et al.. (2026). Higher HbA1c-Hemoglobin Ratio Was Associated With Poor Outcome in Endovascular Thrombectomy Patients.. Behavioural neurology. https://doi.org/10.1155/bn/6668235